Core Viewpoint - Tianchen Medical (688013.SH) has repurchased a total of 2.5053 million shares, representing 3.09% of the company's total share capital, with a total expenditure of approximately RMB 42.4989 million [1] Summary by Category Share Repurchase - The company has completed a share repurchase of 2.5053 million shares, which is 3.09% of its total share capital [1] - The highest price paid for the repurchased shares was RMB 21.00 per share, while the lowest price was RMB 11.87 per share [1] - The total funds used for the repurchase amounted to approximately RMB 42.4989 million, excluding transaction costs such as stamp duty and trading commissions [1]

Group 1 - The core viewpoint of the news is that Tianchen Medical has experienced significant stock price fluctuations and financial growth, with a notable increase in revenue and net profit year-on-year [1][2]. Group 2 - As of October 31, Tianchen Medical's stock price rose by 2.02% to 51.51 CNY per share, with a market capitalization of 4.18 billion CNY [1]. - The company has seen a year-to-date stock price increase of 219.28%, but has experienced a decline of 7.46% in the last five trading days and 13.05% in the last twenty days [1]. - Tianchen Medical's main business involves the research, innovation, and production of high-end surgical staplers, with 77.92% of revenue coming from non-powered products and 22.08% from powered products [1]. - As of September 30, the number of shareholders increased by 11.48% to 4,624, while the average circulating shares per person decreased by 10.29% to 17,550 shares [2]. - For the period from January to September 2025, Tianchen Medical achieved a revenue of 244 million CNY, representing a year-on-year growth of 20.66%, and a net profit of 71.95 million CNY, up 68.29% year-on-year [2]. - The company has distributed a total of 211 million CNY in dividends since its A-share listing, with 179 million CNY distributed over the past three years [2].

Core Insights - The medical device sector experienced a slight increase of 0.37% on October 24, with Mai Lande leading the gains [1] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Medical Device Sector Performance - Top gainers included: - Mai Lande (688273) with a closing price of 41.92, up 6.31%, trading volume of 29,300 hands, and a transaction value of 121 million yuan [1] - Xiangyu Medical (688626) at 53.21, up 6.10%, with a trading volume of 41,100 hands and a transaction value of 216 million yuan [1] - Xiangsheng Medical (688358) at 35.27, up 4.75%, with a trading volume of 38,400 hands and a transaction value of 136 million yuan [1] - Other notable gainers included: - Aohua Endoscopy (688212) at 50.59, up 4.74%, with a transaction value of 225 million yuan [1] - Weisi Medical (688580) at 49.10, up 4.71%, with a transaction value of approximately 99.8 million yuan [1] Decliners in Medical Device Sector - Notable decliners included: - Chenguang Medical (920300) at 17.51, down 8.80%, with a trading volume of 124,000 hands [2] - Toukeng Life (300642) at 22.95, down 5.40%, with a trading volume of 175,700 hands [2] - Haitai New Light (688677) at 48.50, down 5.05%, with a trading volume of 38,800 hands [2] - Other significant decliners included: - Sino Medical (688108) at 28.00, down 4.73%, with a trading volume of 263,700 hands [2] - Tianchen Medical (688013) at 55.66, down 3.98%, with a trading volume of 19,200 hands [2] Capital Flow in Medical Device Sector - The medical device sector saw a net outflow of 654 million yuan from major funds, while retail investors contributed a net inflow of 455 million yuan [2]

Macro Highlights - The main goals for the "14th Five-Year Plan" period include significant achievements in high-quality development, substantial improvement in technological self-reliance, breakthroughs in comprehensive reforms, enhanced social civilization, improved quality of life, major progress in building a beautiful China, and a more solid national security barrier [1] - By 2035, the aim is to significantly elevate China's economic, technological, defense, and comprehensive national strength, with per capita GDP reaching the level of moderately developed countries, leading to a happier and better life for the people and basic realization of socialist modernization [1] Trade Relations - The Ministry of Commerce announced that a Chinese delegation led by Vice Premier He Lifeng will engage in economic and trade consultations with the U.S. in Malaysia from October 24 to 27, focusing on important issues in Sino-U.S. economic relations [1] EU Sanctions Response - The Ministry of Commerce expressed strong dissatisfaction and firm opposition to the EU's decision to sanction Chinese companies, including large oil refineries and traders, during the 19th round of sanctions against Russia, emphasizing the need to protect the legitimate rights and interests of Chinese enterprises [2] State-Owned Enterprises Planning - The State-owned Assets Supervision and Administration Commission held a meeting to discuss the "14th Five-Year Plan" for central enterprises, emphasizing the need to align with the strategic mission assigned by the Party Central Committee and to enhance core functions and competitiveness [3] - The meeting highlighted the importance of optimizing layout and structural adjustments in line with national needs and industry trends, and improving the quality of planning through thorough research and unified thinking [3] Foreign Exchange Management - The Deputy Director of the State Administration of Foreign Exchange encouraged the implementation of innovative and integrated exploratory policies in Shanghai, focusing on the use of AI and big data to enhance foreign exchange services [4] - The aim is to improve the cross-border financial service capabilities of Shanghai while balancing financial openness and security [4] Company News - Huagong Technology reported a 40.92% year-on-year increase in net profit for the first three quarters and is planning to issue H-shares for listing in Hong Kong [8] - Yangjie Technology terminated its acquisition of 100% equity in Better Electronics [8] - Xinda Securities received approval for the issuance of up to 10 billion yuan in technology innovation corporate bonds [8] - Shuangliang Energy plans to raise no more than 1.292 billion yuan for projects related to zero-carbon intelligent manufacturing [8] - New Lai Materials' subsidiary plans to invest 2 billion yuan in semiconductor core component projects [8] - Chuanfa Longmang's subsidiary intends to invest 366 million yuan in a 100,000 tons/year lithium dihydrogen phosphate project [8] - Steel Research High-tech plans to establish a subsidiary and new industrial base in Saudi Arabia [8] - Aote Electronics intends to terminate the smart integration project for intelligent outlets [8] - Shengyi Electronics expects a year-on-year net profit increase of 476% to 519% for the first three quarters [8] - Other companies reported significant year-on-year net profit growth, including Tianeng Heavy Industry (1359.03%), Te Yi Pharmaceutical (985.18%), and Zhuanlei Technology (598.09%) [8][9]

Core Insights - Tianchen Medical (688013.SH) reported its Q3 2025 results on October 24, 2025, highlighting a decrease in institutional investor holdings [1] Institutional Holdings - As of October 23, 2025, three institutional investors disclosed holding a total of 2.2108 million shares of Tianchen Medical, representing 2.72% of the total share capital [1] - The institutional holding percentage decreased by 1.15 percentage points compared to the previous quarter [1] Public Fund Activity - In this reporting period, 61 public funds were not disclosed compared to the previous quarter, including notable funds such as NuAn Multi-Strategy Mixed A and E Fund [1] Foreign Investment - The report noted that there were no new disclosures from foreign institutions compared to the previous quarter, with Inspire Surgical Limited being the only foreign entity mentioned [1]

公司摊薄每股收益为0.90元。 公司最新总资产周转率为0.37次。最新存货周转率为2.52次。 公司股东户数为4624户，前十大股东持股数量为4710.09万股，占总股本比例为58.04%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | l | 陈望宇 | 25.8 | | 2 | 陈望东 | 25.7 | | 3 | 天臣国际医疗科技股份有限公司-2025年员工持股计划 | 0.99 | | 4 | 前海大唐英加(深圳)基金管理有限公司-英加九暹天樽一号私募证券投资基金 | 0.97 | | 5 | 马敬娥 | 0.79 | | ଚ | 何汝豪 | 0.77 | | 7 | 万川基金(深圳)有限公司-万川六号证券投资私募基金 | 0.76 | | 8 | 冯国尤 | 0.73 | | g | 郑佑斌 | 0.70 | | 10 | 林纯青 | 0.67 | 2025年10月24日，天臣医疗(688013.SH)发布2025年三季报。 公司营业总收入为2.44亿元。归母净利润为7194.58万元。经营活动现金净流入为6378.42万元。 公司最新资产 ...

截至2025年10月23日收盘，天臣医疗（688013）报收于57.97元，较前一交易日上涨2.6%，最新总市值 为47.05亿元。该股当日开盘价为56.87元，盘中最高触及58.42元，最低下探至55.2元，成交额达8965.29 万元，换手率为1.94%。 近日，天臣医疗发布《2025年第三季度报告》，披露了公司2025年前三季度的经营数据。根据公告，公 司年初至报告期末实现营业收入243,831,328.07元，同比增长20.66%；归属于上市公司股东的净利润为 71,945,750.36元，同比增长68.29%。同期，经营活动产生的现金流量净额为63,784,159.86元，同比增长 65.58%。 公告显示，利润增长主要得益于公司坚持创新驱动战略，强化国内外双轮驱动，产品持续放量及成本优 化带动毛利率同比上升5.02个百分点。此外，公司总资产达676,021,270.25元，较上年度末增长6.09%； 归属于上市公司股东的所有者权益为599,615,312.18元，较上年度末增长3.13%。 股东方面，截至报告期末，公司普通股股东总数为4,624户。前十大股东中，陈望宇和陈望东分别持股 25.85% ...

Core Insights - Tianchen Medical reported a revenue of 87,663,076.62 yuan for Q3 2025, representing a year-on-year growth of 26.40% [2] - The net profit attributable to shareholders of the listed company was 23,734,176.27 yuan, showing a significant increase of 70.74% compared to the previous year [2] Financial Performance - Revenue for Q3 2025: 87.66 million yuan, up 26.40% year-on-year [2] - Net profit for Q3 2025: 23.73 million yuan, up 70.74% year-on-year [2]

Growth - Yian Technology reported a net profit of 19.03 million yuan in Q3, a year-on-year increase of 10,957% [1] - Hwa Woo Co. achieved a net profit of 24.32 million yuan in Q3, up 4,202% year-on-year [1] - Zhuoyi Information's Q3 net profit reached 17.48 million yuan, reflecting a year-on-year growth of 2,074.65% [1] - Jingrui Electric Materials reported a net profit of 58.61 million yuan in Q3, marking a 938.99% increase year-on-year [1] - Hemei Group's Q3 net profit was 61.75 million yuan, up 706.3% year-on-year [1] - Kelin Electric's Q3 net profit was 56.52 million yuan, a year-on-year increase of 705.48% [1] - Hualu Biological's Q3 net profit reached 70.03 million yuan, reflecting a 619.37% year-on-year growth [1] - Triangle Defense reported a net profit of 105 million yuan in Q3, up 466.32% year-on-year [1] - New Meixing achieved a Q3 net profit of 38.44 million yuan, a year-on-year increase of 357.83% [1] - Hailanxin's Q3 net profit was 5.67 million yuan, reflecting a 342.12% year-on-year growth [1] - Zhenlei Technology reported a net profit of 38.64 million yuan in Q3, up 337.49% year-on-year [1] - Tovey Information's Q3 net profit reached 26.04 million yuan, a year-on-year increase of 239.19% [1] - Wanma Co. reported a net profit of 161 million yuan in Q3, reflecting a 227.70% year-on-year growth [1] - Juhua Co. achieved a Q3 net profit of 1.197 billion yuan, up 186.55% year-on-year [1] - Baofeng Energy reported a net profit of 3.232 billion yuan in Q3, marking a 162.34% increase year-on-year [1] - Sanfu Co. achieved a Q3 net profit of 25.68 million yuan, reflecting a 162.25% year-on-year growth [1] - Chuling Information's Q3 net profit was 248.72 million yuan, up 123.93% year-on-year [1] - Fujilai reported a net profit of 30.32 million yuan in Q3, a year-on-year increase of 113.62% [1] - San Sheng Guojian achieved a Q3 net profit of 209 million yuan, reflecting a 101.41% year-on-year growth [1] - Tianchen Medical reported a net profit of 23.73 million yuan in Q3, up 70.74% year-on-year [1] - Oke Yi's Q3 net profit was 50.35 million yuan, reflecting a 69.31% year-on-year growth [1] - Dingtai High-tech reported a net profit of 123 million yuan in Q3, up 47.05% year-on-year [1] - Yiwei Lithium Energy achieved a Q3 net profit of 1.211 billion yuan, reflecting a 15.13% year-on-year growth [1] - Anpeilong reported a net profit of 30.99 million yuan in Q3, up 14.09% year-on-year [1] - Shengtun Mining's Q3 net profit was 649 million yuan, reflecting an 11.32% year-on-year growth [1] - COSCO Shipping Special reported a net profit of 504 million yuan in Q3, up 6.62% year-on-year [1] - Deep Technology achieved a Q3 net profit of 41.45 million yuan, reflecting a 2.8% year-on-year growth [1] Decline and Loss - Qiaqia Food reported a Q3 net profit of 79.36 million yuan, a year-on-year decrease of 72.58% [2] - Ningbo Jingda's Q3 net profit was 10.83 million yuan, down 65.14% year-on-year [2] - Nanhua Futures reported a Q3 net profit of 120 million yuan, reflecting a year-on-year decline of 6.21% [2] - Zhongwen Online reported a Q3 net loss of 294 million yuan [2] - Tuolisi reported a Q3 net loss of 86.45 million yuan [2] - Taiping Bird reported a Q3 net loss of 49.45 million yuan [2] - COFCO Technology reported a Q3 net loss of 28.06 million yuan [2]

智通财经APP讯，天臣医疗(688013.SH)披露2025年第三季度报告，公司前三季度实现营收2.44亿元，同 比增长20.66%;归属于上市公司股东的净利润7195万元，同比增长68.29%;扣非净利润6620万元，同比增 长71.85%;基本每股收益0.90元。 ...